Piper Sandler Companies (PIPR) has reshaped its senior leadership across investment banking and capital markets, appointing J.P. Peltier as global co-head alongside new co-heads in healthcare, consumer, and equity capital markets.

The reshuffle comes after a steady run in the shares, with a 7-day share price return of 7.2% and a 90-day share price return of 8.34%. The 1-year total shareholder return of 27.17% and 5-year total shareholder return of 308.10% point to momentum that has been resilient over time.

If this kind of leadership-driven story interests you, it can be a good moment to look beyond financials and check out other fast growing stocks with high insider ownership as potential ideas.

With the shares posting strong recent returns and trading around $367.65 versus an analyst price target of $407, the key question is whether Piper Sandler is still attractively priced or whether markets already reflect its future growth potential.

Price-to-Earnings of 27.5x: Is it justified?

Piper Sandler currently trades on a P/E of 27.5x, which sits alongside a last close of US$367.65 and screens as expensive against key benchmarks.

The P/E multiple compares the current share price to earnings per share and is a common way to see how much investors are paying for each dollar of profit in capital markets firms.

For Piper Sandler, the current P/E comes with some context, including earnings growth of 44.1% over the past year and an improvement in net profit margin from 10.8% to 13.8%. At the same time, our DCF model points to an estimated fair value of US$62.31, which is far below the current share price, suggesting the market is placing a rich value on those profits.

The 27.5x P/E is described as expensive compared with both the US Capital Markets industry average of 25.7x and a peer average of 8.6x, indicating a clear valuation premium against both broader sector peers and a narrower peer set.

Result: Price-to-Earnings of 27.5x (OVERVALUED)

However, the rich P/E and the large gap to our DCF output could be vulnerable if revenue growth of 12.86% slows or if sector-wide deal activity softens.

Another View: Our DCF Signals A Very Different Story

While the 27.5x P/E suggests Piper Sandler is expensive, our DCF model lands in a very different place. With an estimated fair value of US$62.31 against a share price of US$367.65, the model implies the stock is heavily overvalued. Which signal you place more weight on will depend on your own approach.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Piper Sandler Companies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 877 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Piper Sandler Companies Narrative

If you look at these numbers and come to a different conclusion, or prefer to test your own view against the data, you can build a full narrative in just a few minutes using Do it your way.

A great starting point for your Piper Sandler Companies research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Piper Sandler has caught your attention, do not stop here, broaden your watchlist with focused themes that can surface fresh, data driven stock ideas.

• Target potential value opportunities by scanning these 877 undervalued stocks based on cash flows that trade at a discount to their cash flow profiles.
• Ride structural technology trends by checking out these 25 AI penny stocks tied to artificial intelligence across different parts of the market.
• Strengthen your income focus by reviewing these 11 dividend stocks with yields > 3% that already offer yields above 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.